Well to maybe get away from the debate about other hyped treatments. I'm curious about dosage in In Vitro cell samples. Has anyone compared the dosage of the antibiotic trial (also infusion, I think) to the dosages reported in the recent press release? Wondering how they compare--though in vitro and in vivo might be very different situations. Just thinking out loud really, wondering how they come up with the most appropriate dosage that would maximize efficacy and minimize risk. I hope human cell and in vivo trials start soon (like already underway). Safety has been fairly well documented. Only potential issue is what kind of stress on the body there might be from clearing/drastically reducing the viral load fairly suddenly (day or two). Does that cause kidney/liver issues? Maybe it's a better treatment to have lower doses spread out over several days. Again, just thinking out loud. I'm sure those decisions are in very capable hands.

Funded the account yesterday for one last buy for a while and now I have to wait and wait and wait. With Fri. being a holiday funds won't clear until next Monday. Seems like yesterday was a good day to make a purchase. Always late to the party...or too early sometimes.